MedTrace Logo

Cognitive Behavioral Therapy for Insomnia to Address Insomnia Symptoms in People With Multiple Sclerosis

NCT03216889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2019-08-28

No results posted yet for this study

Summary

The purpose of this study is to learn if cognitive behavioral therapy for insomnia (CBT-I) will improve sleep quality, fatigue, and quality of life in individuals with multiple sclerosis (MS) with symptoms of insomnia.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy for Insomnia

Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will be one-on-one or in a group.

BEHAVIORAL

Control

Involves attending 1 hour long sessions weekly for 6 weeks. Sessions will involve stretching and thinking games.

Sponsors & Collaborators

  • National Multiple Sclerosis Society

    collaborator OTHER

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Katie Siengsukon, PT, PhD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-29
Primary Completion
2019-08-15
Completion
2019-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03216889 on ClinicalTrials.gov